Cabozantinib 40 Mg Tablet

Name: Cabozantinib 40 Mg Tablet
Brand: Welox Pharma Private Limited
Price: 12000 INR
Availability: InStock

Price 12000 INR/ Bottle

Get a Price/Quote

MOQ : 100 Bottles

Cabozantinib 40 Mg Tablet Specification

Packaging Type
Strip

Indication
Renal cell carcinoma, Medullary thyroid cancer

Pacakaging (Quantity Per Box)
30 Tablets per box

Origin of Medicine
India

Dosage Form
Tablet

Salt Composition
Cabozantinib 40 mg

Life Span
Check expiry on pack

Drug Type
Allopathic

Ingredients
Cabozantinib

Physical Form
Tablet

Function
Anti-cancer medication

Recommended For
Cancer treatment

Dosage
As prescribed by physician

Dosage Guidelines
For oral use only

Suitable For
Adults

Quantity
30 Tablets

Storage Instructions
Store in a cool, dry place

Therapeutic Class
Oncology

Strength
40 mg

Shelf Life
As per pack

Color
White

Route
Oral

Pack Size
30 Tablets

Prescription Required
Yes

Cabozantinib 40 Mg Tablet Trade Information

Minimum Order Quantity
100 Bottles

Supply Ability
5000 Bottles Per Month

Delivery Time
2-10 Days

Cabozantinib 40 Mg Tablet About

Discover the ultimate solution in cancer therapy with Cabozantinib 40 mg Tablet, now available at a reduced price. Sourced from a stellar manufacturer in India, this anti-cancer medication is scarce due to soaring demand in oncology. Each pack includes 30 white tablets, expertly formulated with Cabozantinib 40 mg for adult use. Utilise this offer while supplies last. Designed for oral administration, these tablets ensure targeted efficacy as prescribed by your physician. Store in a cool, dry place to preserve their potency and longevity.

Application and Commercial Usage

Cabozantinib 40 Mg Tablet is designed for oral clinical use, tailored for adults battling renal cell carcinoma and medullary thyroid cancer. Its application surface targets cancerous cells within the body, making it highly effective for commercial oncology settings. Healthcare professionals utilise these tablets in hospitals and specialized cancer treatment centers, ensuring reliable results. The usage type falls strictly under prescription, maintaining controlled distribution for safety and optimal outcomes in adult patients.

Certifications, Sample Policy & Delivery Terms

Cabozantinib 40 Mg Tablet is manufactured under certified pharmaceutical standards in India. For institutional buyers, samples may be provided with applicable charges. Purchases require an official purchase order, and any exchange requests must comply with company policy. Prompt delivery times ensure readiness for healthcare providers, allowing swift initiation of cancer treatment. Please reach out for detailed certification documents, sample policy information, and to secure your purchase with confidence.

FAQ's of Cabozantinib 40 Mg Tablet:

Q: How should Cabozantinib 40 Mg Tablet be used for best results?

A: For optimal efficacy, Cabozantinib 40 Mg Tablet must be taken orally exactly as prescribed by your physician. It is crucial not to alter the dosage or schedule without medical guidance.

Q: What cancers can be treated with Cabozantinib 40 Mg Tablet?

A: This medication is primarily indicated for the treatment of renal cell carcinoma and medullary thyroid cancer in adults, as guided by healthcare professionals.

Q: When should the tablets be taken during cancer therapy?

A: The timing and frequency of Cabozantinib 40 Mg Tablet administration depend on your doctor's prescription and the specific cancer therapy protocol being followed.

Q: Where should Cabozantinib 40 Mg Tablet be stored?

A: Store the tablets in a cool, dry place, away from direct sunlight and moisture. Always refer to the storage instructions on the packaging for best results.

Q: What is the process for purchasing or exchanging Cabozantinib 40 Mg Tablet?

A: Institutional or bulk purchases require a formal purchase order. Exchanges are subject to the supplier's policy and typically adjust only for defects or damage upon delivery.

Q: What are the benefits of utilising this oncology medication?

A: Cabozantinib 40 Mg Tablet offers targeted cancer cell inhibition, supporting improved outcomes for patients with renal or medullary thyroid cancers when used as prescribed.

Tell us about your requirement